Catalysts for Genentech Inc
166 tracked
Oct 21, 2013
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Oct 21, 2013
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Aug 29, 2013
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Aug 19, 2013
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Jul 2, 2013
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 29, 2013
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Feb 22, 2013
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Oct 11, 2012
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Aug 13, 2012
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jun 20, 2012
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 15, 2011
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 15, 2011
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jan 4, 2011
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jan 4, 2011
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jan 4, 2011
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jan 8, 2010
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→